Anebulo Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2026 – 2028)

202620272028
Price/Earnings ratio
-3.83-4.784.14
Price/Sales ratio
3.622.230.77
Earnings per Share (EPS)
$-0.68$-0.54$0.63

Historical Multiples (2020 – 2024)

2020 2021 2022 2023 2024 TTM Median
Valuation Ratios
Price/Earnings ratio
-964.20-5.26-17.81-5.02-8.43-6.65-11.53
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-983.927.438.055.5518.154.556.80
Price/Cash Flow ratio
-1.11K-32.68-22.32-6.08-8.55-8.73-27.50
Price/Free Cash Flow ratio
-1.11K-32.68-22.32-6.08-8.55-8.73-27.50
Price/Earnings Growth ratio
N/A-0.000.22-0.080.26-0.060.07
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
0.59%-0.03%0.18%0.88%N/AN/A0.53%
Return on Assets
-5.76%-139.76%-43.72%-100.53%-201.36%-62.99%-53.35%
Return On Equity
102.04%-141.33%-45.21%-110.66%-215.12%-63.64%-54.42%
Return on Capital Employed
-6.18%-16.87%-45.33%-105.81%-217.93%-64.26%-54.80%
Liquidity Ratios
Current Ratio
N/A89.61N/AN/AN/A47.19N/A
Quick Ratio
13.5282.7128.3821.0413.4647.1955.54
Cash ratio
13.5182.7128.3821.0411.8747.1955.54
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.06N/AN/AN/AN/A0.08N/A
Debt Equity Ratio
-1.17N/AN/AN/AN/A0.08N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
6.67N/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/A-307.10N/AN/AN/A-5.51KN/A
Cash Flow to Debt Ratio
-0.74N/AN/AN/AN/AN/AN/A
Company Equity Multiplier
-17.691.011.031.101.061.081.02
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111111
Cash Flow Coverage Ratio
-0.74N/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
-0.74N/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A